Panagora Asset Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Panagora Asset Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,685	Closed	-$93K	–	2536
2018 Q2	$93K	Sell	10,685 -1,499	-12%	-$13.5K	﹤0.01%	1870
2018 Q1	$124K	Sell	12,184 -6,856	-36%	-$57.6K	﹤0.01%	1803
2017 Q4	$92K	Sell	19,040 -3,060	-14%	-$14.9K	﹤0.01%	1904
2017 Q3	$101K	Buy	22,100 +7,888	+56%	+$37K	﹤0.01%	1882
2017 Q2	$72K	Buy	14,212 +9,340	+192%	+$41.8K	﹤0.01%	1972
2017 Q1	$23K	Hold	4,872	–	–	﹤0.01%	2153
2016 Q4	$27K	Hold	4,872	–	–	﹤0.01%	2184
2016 Q3	$27K	Buy	+4,872	New	+$32.2K	﹤0.01%	2224

Panagora Asset Management's JNP Position: Q3 2018 in Review

Panagora Asset Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 10,685 shares — an estimated $93K sold.

Panagora Asset Management first reported a position in JNP in Q3 2016 and held it in 8 quarters. The position peaked at $124K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Panagora Asset Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Panagora Asset Management sold 10,685 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $93K.
Panagora Asset Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2016 and held it in 8 quarters.
Panagora Asset Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $124K in Q1 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Panagora Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.